This includes people with a BMI of 30 or greater (obesity), or those with a BMI of at least 27 (overweight) who also have type 2 diabetes, cardiovascular disease, or other high-risk factors
For some people, the dosages that are mass produced by manufacturers dont work for certain individuals, which can make using those types of tirzepatide injections much less effective for them
Let it air dry completely before injecting
Lilly describes retatrutide as an investigational once-weekly triple hormone receptor agonist that is legally available only to participants in Lilly clinical trials
If you experience any issues, please contact us directly, and well be happy to help
In an exploratory analysis of CV risk factor changes in people with obesity but not T2D, aggregating data from STEP1 and STEP4 studies of the weight loss effects, a mean placebo-adjusted treatment effect of 5.1 mmHg for SBP and 2.4 mmHg for DPB was reported [17]